Back to top

Vistagen appoints Elissa Cote as Chief Corporate Development Officer

Vistagen (VTGN) announced the appointment of Elissa Cote as Chief Corporate Development Officer. In this role, Cote will lead the evaluation of str...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

VistaGen Therapeutics, Inc. (VTGN)